1. Home
  2. ARDX vs ELME Comparison

ARDX vs ELME Comparison

Compare ARDX & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • ELME
  • Stock Information
  • Founded
  • ARDX 2007
  • ELME 1960
  • Country
  • ARDX United States
  • ELME United States
  • Employees
  • ARDX N/A
  • ELME N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • ELME Real Estate Investment Trusts
  • Sector
  • ARDX Health Care
  • ELME Real Estate
  • Exchange
  • ARDX Nasdaq
  • ELME Nasdaq
  • Market Cap
  • ARDX 1.3B
  • ELME 1.3B
  • IPO Year
  • ARDX 2014
  • ELME N/A
  • Fundamental
  • Price
  • ARDX $3.64
  • ELME $16.01
  • Analyst Decision
  • ARDX Strong Buy
  • ELME Hold
  • Analyst Count
  • ARDX 8
  • ELME 6
  • Target Price
  • ARDX $10.19
  • ELME $17.80
  • AVG Volume (30 Days)
  • ARDX 6.4M
  • ELME 631.3K
  • Earning Date
  • ARDX 05-01-2025
  • ELME 05-01-2025
  • Dividend Yield
  • ARDX N/A
  • ELME 4.50%
  • EPS Growth
  • ARDX N/A
  • ELME N/A
  • EPS
  • ARDX N/A
  • ELME N/A
  • Revenue
  • ARDX $361,706,000.00
  • ELME $243,915,000.00
  • Revenue This Year
  • ARDX $15.74
  • ELME $4.52
  • Revenue Next Year
  • ARDX $34.56
  • ELME $2.58
  • P/E Ratio
  • ARDX N/A
  • ELME N/A
  • Revenue Growth
  • ARDX 127.33
  • ELME 5.31
  • 52 Week Low
  • ARDX $3.62
  • ELME $13.95
  • 52 Week High
  • ARDX $9.20
  • ELME $18.49
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 32.40
  • ELME 52.91
  • Support Level
  • ARDX $3.62
  • ELME $15.73
  • Resistance Level
  • ARDX $5.65
  • ELME $16.30
  • Average True Range (ATR)
  • ARDX 0.31
  • ELME 0.41
  • MACD
  • ARDX -0.15
  • ELME 0.11
  • Stochastic Oscillator
  • ARDX 6.53
  • ELME 78.68

About ARDX Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

Share on Social Networks: